Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priming dose of sufentanil to reduce anesthesia-induced cough
IRCT20251206068224N1Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sufentanil in sufentanil-induced cough (SIC), sponsored by Mashhad University of Medical Sciences. Started Aug 2026; status: recruiting.
02
Drugs
sufentanil
03
Conditions
sufentanil-induced cough (SIC)
Beyond the preview
Go deeper on IRCT20251206068224N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251206068224N1.